当前位置:
X-MOL 学术
›
Emerg. Infect. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023–2024
Emerging Infectious Diseases ( IF 7.2 ) Pub Date : 2024-12-10 , DOI: 10.3201/eid3101.241236 Jakob Ankerhold, Susanne Kessler, Martin Beer, Martin Schwemmle, Kevin Ciminski
中文翻译:
人类免疫因子对甲型流感 (H5N1) 分支 2.3.4.4b 病毒的复制限制(2023-2024 年)
更新日期:2024-12-11
Emerging Infectious Diseases ( IF 7.2 ) Pub Date : 2024-12-10 , DOI: 10.3201/eid3101.241236 Jakob Ankerhold, Susanne Kessler, Martin Beer, Martin Schwemmle, Kevin Ciminski
We show that human myxovirus resistance protein 1 (MxA) suppresses replication of highly pathogenic avian influenza A(H5N1) viruses isolated from mammals in vitro and in MxA-transgenic mice. However, H5N1 can evade MxA restriction through replacement of individual viral polymerase complex components from a human-adapted MxA-resistant strain in vitro.
中文翻译:
人类免疫因子对甲型流感 (H5N1) 分支 2.3.4.4b 病毒的复制限制(2023-2024 年)
我们表明,人粘液病毒抗性蛋白 1 (MxA) 抑制从体外哺乳动物和 MxA 转基因小鼠中分离的高致病性甲型禽流感 (H5N1) 病毒的复制。然而,H5N1 可以通过在体外替换来自人类适应的 MxA 耐药菌株的单个病毒聚合酶复合物成分来逃避 MxA 限制。